FR5183M - - Google Patents

Info

Publication number
FR5183M
FR5183M FR52074A FR52074A FR5183M FR 5183 M FR5183 M FR 5183M FR 52074 A FR52074 A FR 52074A FR 52074 A FR52074 A FR 52074A FR 5183 M FR5183 M FR 5183M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR52074A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR52074A priority Critical patent/FR5183M/fr
Application granted granted Critical
Publication of FR5183M publication Critical patent/FR5183M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR52074A 1966-03-04 1966-03-04 Expired FR5183M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR52074A FR5183M (fr) 1966-03-04 1966-03-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR52074A FR5183M (fr) 1966-03-04 1966-03-04

Publications (1)

Publication Number Publication Date
FR5183M true FR5183M (fr) 1967-06-19

Family

ID=8602908

Family Applications (1)

Application Number Title Priority Date Filing Date
FR52074A Expired FR5183M (fr) 1966-03-04 1966-03-04

Country Status (1)

Country Link
FR (1) FR5183M (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2475890A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Dispositif pour l'administration de matieres medicamenteuses
WO2007118717A2 (fr) * 2006-04-18 2007-10-25 Bayer Schering Pharma Aktiengesellschaft MÉTHODE DE PRÉPARATION DE 4-[17β-METHOXY-17α-MÉTHOXYMÉTHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDÉHYDE (E)-OXIME (ASOPRISNIL)
US8324412B2 (en) 2006-04-18 2012-12-04 Bayer Pharma AG Method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime (asoprisnil)
CN106243178A (zh) * 2016-07-27 2016-12-21 厦门市瑞思医药科技有限公司 一种四烯雌酮的合成方法
CN106397519A (zh) * 2016-08-30 2017-02-15 天津市中升挑战生物科技有限公司 一种烯丙孕素的制备方法
CN106810584A (zh) * 2016-12-28 2017-06-09 宁波第二激素厂 烯丙孕素的合成方法
CN110950920A (zh) * 2019-10-30 2020-04-03 浙江神洲药业有限公司 一种四烯雌酮的制备方法

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2475890A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Dispositif pour l'administration de matieres medicamenteuses
WO2007118717A2 (fr) * 2006-04-18 2007-10-25 Bayer Schering Pharma Aktiengesellschaft MÉTHODE DE PRÉPARATION DE 4-[17β-METHOXY-17α-MÉTHOXYMÉTHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDÉHYDE (E)-OXIME (ASOPRISNIL)
WO2007118717A3 (fr) * 2006-04-18 2008-04-24 Bayer Schering Pharma Ag MÉTHODE DE PRÉPARATION DE 4-[17β-METHOXY-17α-MÉTHOXYMÉTHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDÉHYDE (E)-OXIME (ASOPRISNIL)
US8324412B2 (en) 2006-04-18 2012-12-04 Bayer Pharma AG Method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime (asoprisnil)
CN106243178A (zh) * 2016-07-27 2016-12-21 厦门市瑞思医药科技有限公司 一种四烯雌酮的合成方法
CN106397519A (zh) * 2016-08-30 2017-02-15 天津市中升挑战生物科技有限公司 一种烯丙孕素的制备方法
CN106810584A (zh) * 2016-12-28 2017-06-09 宁波第二激素厂 烯丙孕素的合成方法
CN110950920A (zh) * 2019-10-30 2020-04-03 浙江神洲药业有限公司 一种四烯雌酮的制备方法

Similar Documents

Publication Publication Date Title
FR5183M (fr)
AT281852B (fr)
AU1534566A (fr)
AU1141566A (fr)
FR5067M (fr)
AU1144366A (fr)
AU6703465A (fr)
AU218666A (fr)
AU1393566A (fr)
AU1111066A (fr)
AU855865A (fr)
BE597652A (fr)
BE624001A (fr)
BE618801A (fr)
BE624223A (fr)
BE694058A (fr)
BE694017A (fr)
AU6852465A (fr)
BE694013A (fr)
BE626310A (fr)
BE693939A (fr)
BE693586A (fr)
BE693527A (fr)
AU2390066A (fr)
BE693072A (fr)